Slide drug susceptibility test for the detection of multidrug-resistant tuberculosis in Bangladesh
Tóm tắt
The present study attempted to comparatively assess and establish a suitable detection method of multidrug-resistant tuberculosis (MDR-TB) from previously treated TB cases in Bangladesh. Of 130 Zeihl–Neelsen smear-positive fresh sputum specimens, 112 samples were found to contain viable bacilli as visualized under the light-emitting diode fluorescence microscope after fluorescein di-acetate staining, and 109 positive cases were detected through Löwenstein–Jensen culture. The samples were further tested to survey the drug resistance both by slide drug susceptibility test (DST) and by conventional DST: 94 MDR-TB cases were detected within 10 days through the slide DST, whereas 82 cases were observed through the conventional DST, requiring about 3 months. Because the rapidity, sensitivity and accuracy of the slide DST method were found to be comparatively satisfactory when compared to the conventional DST method; we recommend the slide DST method as the standard diagnostic tool in perspective of Bangladesh for the detection of MDR-TB.
Tài liệu tham khảo
Rahman F, Munshi SK, Kamal SMM, Rahman ASMM, Rahman MM, Noor R. Comparison of different microscopic methods with conventional TB culture. S J Microbiol. 2011;1:46–50.
Zaman K, Yunus M, Arifeen SE, Baqui AH, Sack DA, Hossain S, et al. Prevalence of sputum smear-positive positive tuberculosis in a rural area in Bangladesh. Epidemiol Infect. 2006;134(5):1052–9.
Sharma SK, Kumar S, Saha PK, George N, Arora SK, Gupta D, et al. Prevalence of multidrug-resistant tuberculosis among category II pulmonary tuberculosis patients. Indian J Med Res. 2011;133:312–5.
Shiferaw G, Woldeamanuel Y, Gebevehu M, Girmachew F, Demessie D, Lemma E. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2007;45(4):1093–7.
Mahadev B, Srikantaramu N, James PG, Mathewand R. Bhagirathi comparison between rapid colorimetric mycobacterial isolation and susceptibility testing method and conventional method using LJ medium. Indian J Tuberc. 2010;48:129.
Iqbal R, Shabbir I, Khan SU, Saleem S, Munir K. Multidrug resistance tuberculosis in Lahore. Pak J Med Res. 2008;47:1.
WHO. Global tuberculosis control: surveillance, planning, financing. Geneva: World Health Organization; 2006.
WHO. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva: WHO Press, World Health Organization; 2010.
Caminero CA, Sotgiu G, Zumla A, Migliori GB. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis. 2010;10:621–9.
Lin SYG, Lin SY, Probert W, Lo M, Desmond E. Rapid detection of isoniazid and rifampin resistance mutations in Mycobacterium tuberculosis complex from cultures or smear-positive sputa by use of molecular beacons. J Clin Microbiol. 2004;42:4204–8.
Halse TA, Edwards J, Driscoll JR, Escuyer VE, Musser KA. A pyrosequencing approach to rapidly assess mutations in the rpoB gene associated with rifampin resistance in clinical specimens of Mycobacterium tuberculosis. Washington, DC: 48th Annual ICAAC/IDSA Annual Meeting; 2008.
Johnson R, Streicher EM, Louw GE, Warren RM, van Helden PD, Victor TC. Drug resistance in Mycobacterium tuberculosis. Curr Issues Mol Biol. 2006;8(2):97–111.
Morgan M, Kalantri S, Flores L, Pai M. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2005;5:62.
Dickinson JM, Allen BW, Mitchison DA. Slide culture sensitivity tests. Tubercle. 1989;70:115–21.
Salim AH, Aung KJM, Hossain MA, Van Deun A. Early and rapid microscopy-based diagnosis of the treatment failure and MDR-TB. Int J Tuberc Lung Dis. 2006;10(11):1248–554.
De Kantor IN, Kim SJ, Friden T, Lazlo A, Norvel PY, Reider H, et al. Ziehl-Neelsen staining. In: Laboratory services in tuberculosis control: microscopy, 2nd edn. Geneva: World Health Organization; 1998. p. 27–29.
Ait-Khaled N, Enarson. Tuberculosis bacteriology. In: Tuberculosis. Geneva and Paris: World Health Organization and International Union Against Tuberculosis and Lung Diseases; 2005. p. 13.
Munshi SK, Rahman F, Kamal SMM, Noor R. Comparisons among the diagnostic methods used for the detection of extra-pulmonary tuberculosis in Bangladesh. Int J Mycobacteriol. 2012;1:190–5.
Tsukiyama F, Katoh M, Matsuo Y. Modification of the fluorescent staining method for mycobacterial cells. Hiroshima J Med Sci. 1984;33:293–5.
Gupta PR, Singhal B, Sharma TN, Gupta RB. A modified slide culture technique for quick drug sensitivity testing of M. tuberculosis. Indian J Tuberc. 1992;39:113–6.
Sula L. Fibrin-clot culture technique for isolation of tubercle bacilli from pleural exudates. Am Rev Respir Dis. 1959;80:438–40.
Monkongdee P, McCarthy KD, Chain KP, Tasaneeyapan T, Dung NH, Lan NTN, et al. Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus. Am J Respir Crit Care Med. 2009;180(9):903–8.
De Kantor IN, Kim SJ, Friden T, Lazlo A, Norvel PY, Reider H, et al. Inoculation and incubation procedure. In: Laboratory services in tuberculosis control: culture, 3rd edn. Geneva: World Health Organization; 1998. p. 55.
Kim SJ. Drug susceptibility testing in tuberculosis: methods and reliability of results. Eur Respir J. 2005;25:564–9.
Palomino JC, Portaels F. Simple procedure for drug susceptibility testing of Mycobacterium tuberculosis using a commercial colorimetric assay. Eur J Clin Microbiol Infect Dis. 1999;18:380–3.
Noor R, Akhter S, Rahman F, Munshi SK, Kamal SMM, Feroz F. Frequency of extensively drug-resistant tuberculosis (XDR-TB) among re-treatment cases in NIDCH, Dhaka, Bangladesh. J Infect Chemother. 2012;. doi:10.1007/s10156-012-0490-8.
Kausar MA. Fundamentals of medical sciences. 2nd edn. Asian Color Printing; 2005. p. 79–81.
Moore DA, Mendoza D, Gilman RH, Evans CA, Hollm DMG, Guerra J, et al. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol. 2004;42(10):4412–37.
Bwanga F, Hoffner S, Haili M, Joloba ML. Direct susceptibility testing for multi-drug-resistant tuberculosis: a meta-analysis. BMC Infect Dis. 2009;9:67.
Van Deun A, Barrera L, Fattorini L, Hoffman H, Kam KM, Rigouts L, et al. Mycobacterium tuberculosis strains with highly discordant rifampicin susceptibility test results. J Clin Microbiol. 2009;47(11):3501–6.
Minion J, Leung E, Menzies D, Pai M. Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(10):688–98.